Back to Results

Cemex SAB de CV ADR (CX)

Cemex S.A.B. de C.V. is a Mexico-based construction materials company whose ADR is listed on the NYSE under the symbol CX. Through itself and its subsidiaries, the company produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, and related building materials and services across global markets. Its cement portfolio includes gray ordinary portland, white portland, oil-well, and blended products, while its concrete offerings range from standard and decorative mixes to rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial varieties. Cemex also supplies crushed stone, manufactured sand, gravel, recycled concrete, and Vertua-branded products. In addition, the company provides logistics, transportation, retail, pavement, design and engineering, waste management, industrial construction products, recycling solutions, and alternative raw material services. Founded in 1906, Cemex is headquartered in San Pedro Garza García, Mexico.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CX
$13.61
7.4% Upside
Fair
$14.47
14.2% Upside
Fair
Good
—
—
0.1247
1.0%
July 23, 2026
36.6x
1.4x
1.1x
18.232 B
23.677 B
25.2%
97.1%
5.6
50.3%
274.3%
Send a message
Valuation • Fair Value

Cemex SAB de CV ADR (NYSE-CX) Fair Value by Valuation Model

Compare the primary fair value estimate for Cemex SAB de CV ADR (NYSE-CX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.61

Estimated upside of 7.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$15.54

Discounted cash flow valuation reference.

Ben Graham Formula Value

$3.85

Classic Ben Graham valuation formula reference.

DDM Fair Value

$14.84

Dividend discount model valuation reference.

EPV Fair Value

$12.10

Earnings power value estimate.

Comps Fair Value

$11.53

Comparable-company valuation reference.

Analyst Price Target

$14.47

Analysts imply upside of 14.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Cemex SAB de CV ADR (NYSE-CX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Cemex SAB de CV ADR (NYSE-CX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

16.537 B

Current operating scale indicator.

Revenue Forecast

17.27 B

Forward revenue estimate.

EBITDA

3.031 B

Current operating profitability reference.

EBITDA Forecast

3.47 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Cemex SAB de CV ADR (NYSE-CX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cemex SAB de CV ADR (NYSE-CX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.71

No elevated caution signal from this screen.

Altman Z-Score

5.6

Relatively strong balance-sheet zone.

FCF / Net Income

274.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cemex SAB de CV ADR (NYSE-CX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cemex SAB de CV ADR (NYSE-CX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 23, 2026

Days to Earnings

2

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

1.0%

Income yield reference.

Upcoming Dividend

0.1247

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

50.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Cemex SAB de CV ADR (NYSE-CX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cemex SAB de CV ADR (NYSE-CX) Stock Forecast & Technical Outlook

Review Cemex SAB de CV ADR (NYSE-CX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Cemex SAB de CV ADR (NYSE-CX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Cemex SAB de CV ADR (NYSE-CX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Cemex SAB de CV ADR (NYSE-CX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Cemex SAB de CV ADR (NYSE-CX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Cemex SAB de CV ADR (NYSE-CX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cemex SAB de CV ADR (NYSE-CX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Cemex SAB de CV ADR (NYSE-CX) has a Buy consensus, with 4 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 4
Sell 0
FAQ • Fast Investor Answers

Cemex SAB de CV ADR (NYSE-CX) Stock FAQ

Quick answers about Cemex SAB de CV ADR (NYSE-CX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.61
Estimated upside 7.4%
Valuation Rating
Undervalued
Estimated upside of 7.4%
Analyst Target
$14.47
Implied upside 14.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for Cemex SAB de CV ADR (NYSE-CX) is $13.61. This implies an estimated upside of 7.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 7.4% versus the current market price.

The available analyst price target for Cemex SAB de CV ADR (NYSE-CX) is $14.47. The analyst target implies estimated upside of 14.2%.

The current financial health read for Cemex SAB de CV ADR (NYSE-CX) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cemex SAB de CV ADR (NYSE-CX) is July 23, 2026.

Based on the current data, dividend yield is 1.0%, upcoming dividend amount is 0.1247.

The current P/E ratio listed for Cemex SAB de CV ADR (NYSE-CX) is 36.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Cemex SAB de CV ADR is 18.232 B.

The current enterprise value listed for Cemex SAB de CV ADR is 23.677 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cemex SAB de CV ADR is NYSE-CX, and the stock is listed on NYSE.

Cemex SAB de CV ADR (NYSE-CX) is listed on NYSE.

The current debt-to-total-capital ratio listed for Cemex SAB de CV ADR is 25.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cemex SAB de CV ADR is 97.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Construction Materials Stocks on NYSE View more

CRH PLC (CRH) CRH PLC (CRH)
Vulcan Materials Company (VMC) Vulcan Materials Company (VMC)
Martin Marietta Materials Inc (MLM) Martin Marietta Materials Inc (MLM)
Amrize AG (AMRZ) Amrize AG (AMRZ)
James Hardie Industries PLC ADR (JHX) James Hardie Industries PLC ADR (JHX)
Eagle Materials Inc (EXP) Eagle Materials Inc (EXP)
Knife River Corp (KNF) Knife River Corp (KNF)
Titan America SA (TTAM) Titan America SA (TTAM)
Loma Negra Compania Industrial Argentina SA ADR (LOMA) Loma Negra Compania Industrial Argentina SA ADR (LOMA)
Cementos Pacasmayo SAA ADR (CPAC) Cementos Pacasmayo SAA ADR (CPAC)